Literature DB >> 31577366

Exercise therapy for chronic fatigue syndrome.

Lillebeth Larun1, Kjetil G Brurberg, Jan Odgaard-Jensen, Jonathan R Price.   

Abstract

Editorial Note: A statement from the Editor in Chief about this review and its planned update is available here: https://www.cochrane.org/news/cfs
BACKGROUND: Chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME) is a serious disorder characterised by persistent postexertional fatigue and substantial symptoms related to cognitive, immune and autonomous dysfunction. There is no specific diagnostic test, therefore diagnostic criteria are used to diagnose CFS. The prevalence of CFS varies by type of diagnostic criteria used. Existing treatment strategies primarily aim to relieve symptoms and improve function. One treatment option is exercise therapy.
OBJECTIVES: The objective of this review was to determine the effects of exercise therapy for adults with CFS compared with any other intervention or control on fatigue, adverse outcomes, pain, physical functioning, quality of life, mood disorders, sleep, self-perceived changes in overall health, health service resources use and dropout. SEARCH
METHODS: We searched the Cochrane Common Mental Disorders Group controlled trials register, CENTRAL, and SPORTDiscus up to May 2014, using a comprehensive list of free-text terms for CFS and exercise. We located unpublished and ongoing studies through the World Health Organization International Clinical Trials Registry Platform up to May 2014. We screened reference lists of retrieved articles and contacted experts in the field for additional studies. SELECTION CRITERIA: We included randomised controlled trials (RCTs) about adults with a primary diagnosis of CFS, from all diagnostic criteria, who were able to participate in exercise therapy. DATA COLLECTION AND ANALYSIS: Two review authors independently performed study selection, 'Risk of bias' assessments and data extraction. We combined continuous measures of outcomes using mean differences (MDs) or standardised mean differences (SMDs). To facilitate interpretation of SMDs, we re-expressed SMD estimates as MDs on more common measurement scales. We combined dichotomous outcomes using risk ratios (RRs). We assessed the certainty of evidence using GRADE. MAIN
RESULTS: We included eight RCTs with data from 1518 participants.Exercise therapy lasted from 12 weeks to 26 weeks. The studies measured effect at the end of the treatment and at long-term follow-up, after 50 weeks or 72 weeks.Seven studies used aerobic exercise therapies such as walking, swimming, cycling or dancing, provided at mixed levels in terms of intensity of the aerobic exercise from very low to quite rigorous, and one study used anaerobic exercise. Control groups consisted of passive control, including treatment as usual, relaxation or flexibility (eight studies); cognitive behavioural therapy (CBT) (two studies); cognitive therapy (one study); supportive listening (one study); pacing (one study); pharmacological treatment (one study) and combination treatment (one study).Most studies had a low risk of selection bias. All had a high risk of performance and detection bias.Exercise therapy compared with 'passive' controlExercise therapy probably reduces fatigue at end of treatment (SMD -0.66, 95% CI -1.01 to -0.31; 7 studies, 840 participants; moderate-certainty evidence; re-expressed MD -3.4, 95% CI -5.3 to -1.6; scale 0 to 33). We are uncertain if fatigue is reduced in the long term because the certainty of the evidence is very low (SMD -0.62, 95 % CI -1.32 to 0.07; 4 studies, 670 participants; re-expressed MD -3.2, 95% CI -6.9 to 0.4; scale 0 to 33).We are uncertain about the risk of serious adverse reactions because the certainty of the evidence is very low (RR 0.99, 95% CI 0.14 to 6.97; 1 study, 319 participants).Exercise therapy may moderately improve physical functioning at end of treatment, but the long-term effect is uncertain because the certainty of the evidence is very low. Exercise therapy may also slightly improve sleep at end of treatment and at long term. The effect of exercise therapy on pain, quality of life and depression is uncertain because evidence is missing or of very low certainty.Exercise therapy compared with CBTExercise therapy may make little or no difference to fatigue at end of treatment (MD 0.20, 95% CI -1.49 to 1.89; 1 study, 298 participants; low-certainty evidence), or at long-term follow-up (SMD 0.07, 95% CI -0.13 to 0.28; 2 studies, 351 participants; moderate-certainty evidence).We are uncertain about the risk of serious adverse reactions because the certainty of the evidence is very low (RR 0.67, 95% CI 0.11 to 3.96; 1 study, 321 participants).The available evidence suggests that there may be little or no difference between exercise therapy and CBT in physical functioning or sleep (low-certainty evidence) and probably little or no difference in the effect on depression (moderate-certainty evidence). We are uncertain if exercise therapy compared to CBT improves quality of life or reduces pain because the evidence is of very low certainty.Exercise therapy compared with adaptive pacingExercise therapy may slightly reduce fatigue at end of treatment (MD -2.00, 95% CI -3.57 to -0.43; scale 0 to 33; 1 study, 305 participants; low-certainty evidence) and at long-term follow-up (MD -2.50, 95% CI -4.16 to -0.84; scale 0 to 33; 1 study, 307 participants; low-certainty evidence).We are uncertain about the risk of serious adverse reactions (RR 0.99, 95% CI 0.14 to 6.97; 1 study, 319 participants; very low-certainty evidence).The available evidence suggests that exercise therapy may slightly improve physical functioning, depression and sleep compared to adaptive pacing (low-certainty evidence). No studies reported quality of life or pain.Exercise therapy compared with antidepressantsWe are uncertain if exercise therapy, alone or in combination with antidepressants, reduces fatigue and depression more than antidepressant alone, as the certainty of the evidence is very low. The one included study did not report on adverse reactions, pain, physical functioning, quality of life, sleep or long-term results. AUTHORS'
CONCLUSIONS: Exercise therapy probably has a positive effect on fatigue in adults with CFS compared to usual care or passive therapies. The evidence regarding adverse effects is uncertain. Due to limited evidence it is difficult to draw conclusions about the comparative effectiveness of CBT, adaptive pacing or other interventions. All studies were conducted with outpatients diagnosed with 1994 criteria of the Centers for Disease Control and Prevention or the Oxford criteria, or both. Patients diagnosed using other criteria may experience different effects.

Entities:  

Year:  2019        PMID: 31577366      PMCID: PMC6953363          DOI: 10.1002/14651858.CD003200.pub8

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  68 in total

1.  Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

Authors:  M C Gulliford; O C Ukoumunne; S Chinn
Journal:  Am J Epidemiol       Date:  1999-05-01       Impact factor: 4.897

Review 2.  Exercise prescription for individuals with chronic fatigue syndrome.

Authors:  Karen E Wallman; Alan R Morton; Carmel Goodman; Robert Grove
Journal:  Med J Aust       Date:  2005-08-01       Impact factor: 7.738

3.  Effects of a self-regulation based physical activity program (the "4-STEPS") for unexplained chronic fatigue: a randomized controlled trial.

Authors:  M Marques; V De Gucht; I Leal; S Maes
Journal:  Int J Behav Med       Date:  2015-04

4.  [Effect of Tuina on oxygen free radicals metabolism in patients with chronic fatigue syndrome].

Authors:  Chang-Zheng Liu; Bo Lei
Journal:  Zhongguo Zhen Jiu       Date:  2010-11

5.  Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome.

Authors:  P Powell; R P Bentall; F J Nye; R H Edwards
Journal:  BMJ       Date:  2001-02-17

6.  Triangulating patient and clinician perspectives on clinically important differences in health-related quality of life among patients with heart disease.

Authors:  Kathleen W Wyrwich; Stacie M Metz; Kurt Kroenke; William M Tierney; Ajit N Babu; Fredric D Wolinsky
Journal:  Health Serv Res       Date:  2007-12       Impact factor: 3.402

7.  Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome.

Authors:  A J Wearden; R K Morriss; R Mullis; P L Strickland; D J Pearson; L Appleby; I T Campbell; J A Morris
Journal:  Br J Psychiatry       Date:  1998-06       Impact factor: 9.319

Review 8.  Pain assessment: global use of the Brief Pain Inventory.

Authors:  C S Cleeland; K M Ryan
Journal:  Ann Acad Med Singapore       Date:  1994-03       Impact factor: 2.473

Review 9.  Healthy hearts--and the universal benefits of being physically active: physical activity and health.

Authors:  Steven N Blair; Jeremy N Morris
Journal:  Ann Epidemiol       Date:  2009-04       Impact factor: 3.797

10.  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

Authors:  D J Buysse; C F Reynolds; T H Monk; S R Berman; D J Kupfer
Journal:  Psychiatry Res       Date:  1989-05       Impact factor: 3.222

View more
  25 in total

Review 1.  The Updated NICE Guidance Exposed the Serious Flaws in CBT and Graded Exercise Therapy Trials for ME/CFS.

Authors:  Mark Vink; Alexandra Vink-Niese
Journal:  Healthcare (Basel)       Date:  2022-05-12

Review 2.  Exercise training for adults undergoing maintenance dialysis.

Authors:  Amelie Bernier-Jean; Nadim A Beruni; Nicola P Bondonno; Gabrielle Williams; Armando Teixeira-Pinto; Jonathan C Craig; Germaine Wong
Journal:  Cochrane Database Syst Rev       Date:  2022-01-12

Review 3.  Brain Fog in Hypothyroidism: What Is It, How Is It Measured, and What Can Be Done About It.

Authors:  Mary H Samuels; Lori J Bernstein
Journal:  Thyroid       Date:  2022-05-05       Impact factor: 6.506

4.  Effectiveness a herbal medicine (Sipjeondaebo-tang) on adults with chronic fatigue syndrome: A randomized, double-blind, placebo-controlled trial.

Authors:  Seungwon Shin; Soo Jung Park; Minwoo Hwang
Journal:  Integr Med Res       Date:  2020-09-22

5.  Exploring Changes in Activity Patterns in Individuals with Chronic Pain.

Authors:  Elena Rocío Serrano-Ibáñez; Rebecca Bendayan; Carmen Ramírez-Maestre; Alicia Eva López-Martínez; Gema Teresa Ruíz-Párraga; Madelon Peters; Rosa Esteve
Journal:  Int J Environ Res Public Health       Date:  2020-05-19       Impact factor: 3.390

6.  Cost-effectiveness of Interventions for Chronic Fatigue Syndrome or Myalgic Encephalomyelitis: A Systematic Review of Economic Evaluations.

Authors:  M Cochrane; E Mitchell; W Hollingworth; E Crawley; D Trépel
Journal:  Appl Health Econ Health Policy       Date:  2021-03-01       Impact factor: 3.686

7.  Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.

Authors:  Sofie Bliddal; Karina Banasik; Ole Birger Pedersen; Janna Nissen; Lisa Cantwell; Michael Schwinn; Morten Tulstrup; David Westergaard; Henrik Ullum; Søren Brunak; Niels Tommerup; Bjarke Feenstra; Frank Geller; Sisse Rye Ostrowski; Kirsten Grønbæk; Claus Henrik Nielsen; Susanne Dam Nielsen; Ulla Feldt-Rasmussen
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379

8.  The impact of exercise intervention for patients undergoing hemodialysis on fatigue and quality of life: A protocol for systematic review and meta-analysis.

Authors:  Fan Zhang; Yan Bai; Xing Zhao; Liuyan Huang; Ying Zhang; Huachun Zhang
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

Review 9.  Systematic review of randomized controlled trials for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).

Authors:  Do-Young Kim; Jin-Seok Lee; Samuel-Young Park; Soo-Jin Kim; Chang-Gue Son
Journal:  J Transl Med       Date:  2020-01-06       Impact factor: 5.531

10.  'Function First-Be Active, Stay Independent'-promoting physical activity and physical function in people with long-term conditions by primary care: a protocol for a realist synthesis with embedded co-production and co-design.

Authors:  Rebecca-Jane Law; Lynne Williams; Joseph Langley; Christopher Burton; Beth Hall; Julia Hiscock; Val Morrison; Andrew Lemmey; Rebecca Partridge; Candida Lovell-Smith; John Gallanders; Nefyn Williams
Journal:  BMJ Open       Date:  2020-02-09       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.